Results: 1-21 |
Results: 21

Authors: Sakamoto, H Mashima, T Sato, S Hashimoto, Y Yamori, T Tsuruo, T
Citation: H. Sakamoto et al., Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells, CLIN CANC R, 7(8), 2001, pp. 2513-2518

Authors: Fukushima, S Takeuchi, Y Kishimoto, S Yamashita, S Uetsuki, K Shirakawa, S Suzuki, M Furuta, K Noyori, R Sasaki, H Kikuchi, Y Kita, T Yamori, T Sawada, J Kojima, M Hazato, A Kurozumi, S Fukushima, M
Citation: S. Fukushima et al., Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-Delta(7)-prostaglandin A(1) methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826), ANTI-CANC D, 12(3), 2001, pp. 221-234

Authors: Miyata, F Yoshida, S Yamori, T Katoh, T
Citation: F. Miyata et al., An efficient and expeditious synthesis of a novel 5H-naphth[1',2': 5,6][1,4]oxazino[2,3-b]quinoxalin-5-one and its unique inhibitory activity againsta panel of human cancer cell lines, HETEROCYCLE, 54(2), 2001, pp. 619

Authors: Iwasa, K Moriyasu, M Yamori, T Turuo, T Lee, DU Wiegrebe, W
Citation: K. Iwasa et al., In vitro cytotoxicity of the protoberberine-type alkaloids, J NAT PROD, 64(7), 2001, pp. 896-898

Authors: Komatsu, Y Tomizaki, K Tsukamoto, M Kato, T Nishino, NK Sato, SG Yamori, T Tsuruo, T Furumai, R Yoshida, M Horinouchi, S Hayashi, H
Citation: Y. Komatsu et al., Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity, CANCER RES, 61(11), 2001, pp. 4459-4466

Authors: Saji, H Koike, M Yamori, T Saji, S Seiki, M Matsushima, K Toi, M
Citation: H. Saji et al., Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, CANCER, 92(5), 2001, pp. 1085-1091

Authors: Omoto, Y Kobayashi, Y Nishida, K Tsuchiya, E Eguchi, H Nakagawa, K Ishikawa, Y Yamori, T Iwase, H Fujii, Y Warner, M Gustafsson, JA Hayashi, S
Citation: Y. Omoto et al., Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers, BIOC BIOP R, 285(2), 2001, pp. 340-347

Authors: Dan, S Yamori, T
Citation: S. Dan et T. Yamori, Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells, BIOC BIOP R, 280(3), 2001, pp. 861-867

Authors: Su, W Ito, T Oyama, T Kitagawa, T Yamori, T Fujiwara, H Matsuda, H
Citation: W. Su et al., The direct effect of IL-12 on tumor cells: IL-12 acts directly on tumor cells to activate NF-kappa B and enhance IFN-gamma-mediated STAT1 phosphorylation, BIOC BIOP R, 280(2), 2001, pp. 503-512

Authors: Oyama, T Miyoshi, Y Koyama, K Nakagawa, H Yamori, T Ito, T Matsuda, H Arakawa, H Nakamura, Y
Citation: T. Oyama et al., Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis, GENE CHROM, 29(1), 2000, pp. 9-15

Authors: Egawa, K Yamori, T Nosaka, C Kunimoto, S Takeuchi, T Nose, K
Citation: K. Egawa et al., Deoxynybomycin is a selective anti-tumor agent inducing apoptosis and inhibiting topoisomerase I, BIOL PHAR B, 23(9), 2000, pp. 1036-1040

Authors: Akiyama, N Hijikata, M Kobayashi, A Yamori, T Tsuruo, T Natori, S
Citation: N. Akiyama et al., Anti-tumor effect of N-beta-alanyl-5-S-glutathionyl-dihydroxyphenylalanine(5-S-GAD), a novel anti-bacterial substance from an insect, ANTICANC R, 20(1A), 2000, pp. 357-362

Authors: Kuroda, M Mimaki, Y Sashida, Y Yamori, T Tsuruo, T
Citation: M. Kuroda et al., Galtonioside A, a novel cytotoxic cholestane glycoside from Galtonia candicans, TETRAHEDR L, 41(2), 2000, pp. 251-255

Authors: Hosokawa, N Iinuma, H Takeuchi, T Sato, S Yamori, T Tsuchiya, KS Hori, M
Citation: N. Hosokawa et al., Anticancer and some biological activities of thiazinotrienomycin B, J ANTIBIOT, 53(3), 2000, pp. 306-308

Authors: Mimaki, Y Kuroda, M Sashida, Y Yamori, T Tsuruo, T
Citation: Y. Mimaki et al., Candicanoside A, a novel cytotoxic rearranged cholestane glycoside from Galtonia candicans, HELV CHIM A, 83(10), 2000, pp. 2698-2704

Authors: Hoshino, R Chatani, Y Yamori, T Tsuruo, T Oka, H Yoshida, O Shimada, Y Ari-i, S Wada, H Fujimoto, J Kohno, M
Citation: R. Hoshino et al., Constitutive activation of the 41-/43-kDa mitogen-activated protein kinasesignaling pathway in human tumors, ONCOGENE, 18(3), 1999, pp. 813-822

Authors: Hirai, KI Koyama, J Pan, JH Simamura, E Shimada, H Yamori, T Sato, S Tagahara, K Tsuruo, T
Citation: Ki. Hirai et al., Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells, CANCER DET, 23(6), 1999, pp. 539-550

Authors: Iwasa, K Nishiyama, Y Ichimaru, M Moriyasu, M Kim, HS Wataya, Y Yamori, T Takashi, T Lee, DU
Citation: K. Iwasa et al., Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity, EUR J MED C, 34(12), 1999, pp. 1077-1083

Authors: Naasani, I Seimiya, H Yamori, T Tsuruo, T
Citation: I. Naasani et al., FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis, CANCER RES, 59(16), 1999, pp. 4004-4011

Authors: Yamori, T Matsunaga, A Sato, S Yamazaki, K Komi, A Ishizu, K Mita, I Edatsugi, H Matsuba, Y Takezawa, K Nakanishi, O Kohno, H Nakajima, Y Komatsu, H Andoh, T Tsuruo, T
Citation: T. Yamori et al., Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel, CANCER RES, 59(16), 1999, pp. 4042-4049

Authors: Chen, ZH Naito, M Hori, S Mashima, T Yamori, T Tsuruo, T
Citation: Zh. Chen et al., A human IAP-family gene, Apollon, expressed in human brain cancer cells, BIOC BIOP R, 264(3), 1999, pp. 847-854
Risultati: 1-21 |